Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage

被引:73
作者
Corral, J
Iniesta, JA
González-Conejero, R
Villalón, M
Vicente, V
机构
[1] Hosp Virgen Arrixaca, Emergency Serv, Murcia, Spain
[2] Hosp Gen Univ, Div Neurol, Murcia, Spain
[3] Hosp Gen Univ, Hematol & Med Oncol Serv, Murcia, Spain
关键词
D O I
10.1182/blood.V97.10.2979
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intracranial hemorrhage is the third most frequent cause of cerebrovascular disease, but few genetic risk factors have been associated with its development. Recently, it has been reported that some polymorphisms that affect clotting factors increase the risk for thrombosis. However, reports have analyzed the effect of polymorphisms influencing the hemostatic state in bleeding disorders insufficiently. A case-control study was conducted of 201 patients with spontaneous intracranial hemorrhage and 201 control subjects matched for age, race, sex, and selected risk factors (hypertension, smoking, and alcohol consumption). Genomic polymerase chain reaction was used to analyze the prevalence of 4 polymorphisms: factor V Leiden, prothrombin 20210A, factor VII-323 Del/Ins of a decanucleotide, and factor XIII V34L. Subjects with factor V Leiden had decreased risk for spontaneous intracranial hemorrhage (odds ratio, 0.19; 95% confidence interval, 0.03-0.95). The frequency of the prothrombin 20210A/G genotype was also lower among patients than controls (1.5% vs 3%, respectively). Moreover, carriers of the -323 Ins allele of factor VII had a 1.54-fold risk for intracranial hemorrhage (95% Cl, 1.03-2.72). Finally, no significant differences were observed in the prevalence of factor XIII V34L polymorphism between patients and controls. Therefore, new genetic factors affecting the risk for spontaneous intracranial hemorrhage were identified. These data, together with the relevance of these polymorphisms in thrombotic diseases, support the idea that a polymorphism may play opposite roles in thrombosis and hemorrhage, suggesting an explanation for the high frequency of these polymorphisms in the general population. (Blood. 2001;97-.2979-2982) (C) 2001 by The American Society of Hematology.
引用
收藏
页码:2979 / 2982
页数:4
相关论文
共 27 条
  • [1] COMBINED FACTOR-VIII FACTOR-XI DEFICIENCY MAY CAUSE INTRA-FAMILIAL CLINICAL VARIABILITY IN HEMOPHILIA-A AMONG ASHKENAZI JEWS
    BERG, LP
    VARON, D
    MARTINOWITZ, U
    WIELAND, K
    KAKKAR, VV
    COOPER, DN
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (01) : 59 - 62
  • [2] Bertina R M, 1998, Curr Opin Hematol, V5, P339, DOI 10.1097/00062752-199809000-00006
  • [3] Bertina RM, 1999, THROMB HAEMOSTASIS, V82, P601
  • [4] MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C
    BERTINA, RM
    KOELEMAN, BPC
    KOSTER, T
    ROSENDAAL, FR
    DIRVEN, RJ
    DERONDE, H
    VANDERVELDEN, PA
    REITSMA, PH
    [J]. NATURE, 1994, 369 (6475) : 64 - 67
  • [5] Factor XIII Val 34 Leu - A novel association with primary intracerebral hemorrhage
    Catto, AJ
    Kohler, HP
    Bannan, S
    Stickland, M
    Carter, A
    Grant, PJ
    [J]. STROKE, 1998, 29 (04) : 813 - 816
  • [6] Corral J, 2000, HAEMATOLOGICA, V85, P293
  • [7] PHYSIOLOGICAL ANTICOAGULATION - RESISTANCE TO ACTIVATED PROTEIN-C AND VENOUS THROMBOEMBOLISM
    DAHLBACK, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (03) : 923 - 927
  • [8] A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men
    Doggen, CJM
    Cats, VM
    Bertina, RM
    Reitsma, PH
    Vandenbroucke, JP
    Rosendaal, FR
    [J]. THROMBOSIS AND HAEMOSTASIS, 1998, 80 (02) : 281 - 285
  • [9] Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease
    Girelli, D
    Russo, C
    Ferraresi, P
    Olivieri, O
    Pinotti, M
    Friso, S
    Manzato, F
    Mazzucco, A
    Bernardi, F
    Corrocher, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (11) : 774 - 780
  • [10] FACTOR-V LEIDEN - AN UNSELFISH GENE
    HAJJAR, KA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (23) : 1585 - 1587